It was reported that the patient experienced an arrhythmia that met medical doctor notification (mdn) requirements that was not transmitted during the wear period.Investigation concluded that the arrhythmia was not transmitted during the wear period because the gateway experienced a hardware malfunction and was unable to communicate with the cell module.No adverse events such as death or serious injury are known to have occurred, however the healthcare provider (hcp) stated that there was a delay in installing a pacemaker, and the patient later experienced a syncopal episode.
|
It was reported that the patient experienced an arrhythmia that met medical doctor notification (mdn) requirements that was not transmitted during the wear period.No adverse events such as death or serious injury are known to have occurred, however the hcp stated that there was a delay in installing a pacemaker, and the patient later experienced a syncopal episode.The device was activated and the next day, the gateway experienced a hardware malfunction and was unable to communicate with the cell module.On the same day, the patient experienced an arrhythmia that was not transmitted due to the gateway malfunction.Once the device was returned, a final report was generated on day 15, and the hcp was notified of the arrhythmia.On day 18, the patient experienced a syncopal episode and sought care at a hospital.On day 19, the hcp stated that the patient was sent to the emergency department for a pacemaker.This event is being reported per 21 cfr 803 as a product problem / malfunction.This report does not constitute an admission by irhythm that the product described in this report has any defects or has malfunctioned.These terms are included in form fda 3500a and are fixed terms for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.
|